HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamide

inhibits MAP kinase kinase; structure in first source
Also Known As:
CI 1040; CI-1040; PD 184352; PD-184352; PD184352
Networked: 70 relevant articles (3 outcomes, 10 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Dent, Paul: 12 articles (04/2012 - 01/2002)
2. Grant, Steven: 12 articles (04/2012 - 01/2002)
3. Dai, Yun: 7 articles (04/2012 - 11/2002)
4. Kohno, Michiaki: 5 articles (04/2013 - 05/2003)
5. Tanimura, Susumu: 5 articles (04/2013 - 05/2003)
6. Yacoub, Adly: 5 articles (08/2011 - 11/2005)
7. Mitchell, Clint: 4 articles (08/2011 - 11/2005)
8. Rahmani, Mohamed: 4 articles (11/2009 - 01/2002)
9. Watanabe, Kazushi: 3 articles (04/2013 - 02/2010)
10. Grant, S: 3 articles (07/2011 - 07/2001)

Related Diseases

1. Neoplasms (Cancer)
2. Breast Neoplasms (Breast Cancer)
3. Carcinoma (Carcinomatosis)
4. Leukemia
5. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)

Related Drugs and Biologics

1. PD 0325901
2. soblidotin (TZT 1027)
3. vinorelbine (Navelbine)
4. Phosphotransferases (Kinase)
5. 7-hydroxystaurosporine (UCN 01)
6. 2- (2- chloro- 4- iodophenylamino)- N- cyclopropylmethoxy- 3,4- difluorobenzamide
7. Protein Kinases (Protein Kinase)
8. AZD 6244
9. PD 98059
10. sorafenib (BAY 43-9006)

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Oral Administration
3. Nephrectomy
4. Ligation
5. Aftercare (After-Treatment)